The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Daratumumab (Dara) and hyperfractionated cyclophosphamide (HyperCy)/dexamethasone (Dex) with and without carfilzomib (Car) for the treatment of relapsed/refractory multiple myeloma (RRMM).
 
Brandon R. Shank
No Relationships to Disclose
 
Brian Primeaux
No Relationships to Disclose
 
Sandra B. Horowitz
No Relationships to Disclose
 
Erin K. Yeung
No Relationships to Disclose
 
Irene Y. Lee
No Relationships to Disclose
 
Gregory Peter Kaufman
Research Funding - Janssen
 
Hans Chulhee Lee
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Research Funding - Amgen; Celgene; Daiichi Sankyo; GlaxoSmithKline; Janssen; Takeda
 
Elisabet Esteve Manasanch
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; Sanofi; Takeda/Millennium
Research Funding - JW Pharmaceutical; Merck; Novartis; Quest Diagnostics; Sanofi
 
Krina K. Patel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Pfizer; Precision Biosciences; Takeda
Research Funding - Abbvie; Celgene; Cellectis; Poseida Therapeutics; Takeda
Patents, Royalties, Other Intellectual Property - ZIOPHARM Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen; Pfizer; Poseida Therapeutics; Precision Biosciences
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; FORMA Therapeutics; GlaxoSmithKline; Ionis Pharmaceuticals; Janssen Biotech; Juno Therapeutics; Kite, a Gilead company; Legend Biotech; Molecular Partners; Sanofi; SERVIER; Takeda
Research Funding - BioTheryX
 
Donna M. Weber
No Relationships to Disclose
 
Sheeba K. Thomas
Research Funding - Acerta Pharma; Amgen/Onyx; Bristol-Myers Squibb; Xencor
(OPTIONAL) Uncompensated Relationships - Ascentage Pharma